These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 5329226)

  • 21. Study protocol for J-SUPPORT 1604 (J-FORCE): a randomized, double blind, placebo-controlled Phase III study evaluating olanzapine (5 mg) plus standard triple antiemetic therapy for prevention of chemotherapy induced nausea and vomiting in patients receiving cisplatin-based highly emetogenic chemotherapy.
    Hashimoto H; Abe M; Yanai T; Yamaguchi T; Zenda S; Uchitomi Y; Fukuda H; Mori M; Iwasa S; Yamamoto N; Ohe Y
    Jpn J Clin Oncol; 2018 Oct; 48(10):950-952. PubMed ID: 30124989
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Postoperative nausea and vomiting treated with domperidone (r 33812) an open and a double-blind study.
    Stockman A; Caron D; Gallant J; Boghaert A
    Anaesthesist; 1978 Nov; 27(11):540-3. PubMed ID: 727428
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methylprednisolone in cis-platinum induced nausea and emesis: a placebo-controlled trial.
    Metz CA; Freedman RS; Magrina JF
    Gynecol Oncol; 1987 May; 27(1):84-9. PubMed ID: 3552909
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Randomized, placebo-controlled trial of trimethobenzamide to control nausea and vomiting during initiation and continued treatment with subcutaneous apomorphine injection.
    Hauser RA; Isaacson S; Clinch T;
    Parkinsonism Relat Disord; 2014 Nov; 20(11):1171-6. PubMed ID: 25239603
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Double-blind evaluation of hydroxyzine as an antiemetic in pregancy.
    Erez S; Schifrin BS; Dirim O
    J Reprod Med; 1971 Jul; 7(1):35-7. PubMed ID: 4948652
    [No Abstract]   [Full Text] [Related]  

  • 26. Cytostatic therapy-induced vomiting inhibited by domperidone. A double-blind cross-over study.
    Hamers J
    Biomedicine; 1978 Nov; 29(7):242-4. PubMed ID: 371690
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phase I-trial of clebopride, a new antiemetic, in chemotherapy--induced nausea and vomiting.
    Lenz HJ; Schuler U; Hicking W; Ehninger G
    Eur J Clin Pharmacol; 1990; 38(5):525. PubMed ID: 2379541
    [No Abstract]   [Full Text] [Related]  

  • 28. Results of antiemetic management in terminal illness.
    Lichter I
    J Palliat Care; 1993; 9(2):19-21. PubMed ID: 8397302
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Which antiemetic?
    Lichter I
    J Palliat Care; 1993; 9(1):42-50. PubMed ID: 8492237
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparison of the efficacy, safety, and patient satisfaction of ondansetron versus droperidol as antiemetics for elective outpatient surgical procedures. S3A-409 and S3A-410 Study Groups.
    Fortney JT; Gan TJ; Graczyk S; Wetchler B; Melson T; Khalil S; McKenzie R; Parrillo S; Glass PS; Moote C; Wermeling D; Parasuraman TV; Duncan B; Creed MR
    Anesth Analg; 1998 Apr; 86(4):731-8. PubMed ID: 9539593
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiemetic efficacy of ondansetron after outpatient laparoscopy.
    Bodner M; White PF
    Anesth Analg; 1991 Sep; 73(3):250-4. PubMed ID: 1831016
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacological management of chemotherapy-induced nausea and vomiting in children with cancer.
    Cefalo MG; Ruggiero A; Maurizi P; Attinà G; Arlotta A; Riccardi R
    J Chemother; 2009 Dec; 21(6):605-10. PubMed ID: 20071282
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fixed Combination Antiemetic: A Literature Review on Prevention of Chemotherapy-Induced Nausea and Vomiting Using Netupitant/Palonosetron.
    Clark-Snow RA; Vidall C; Börjeson S; Jahn P
    Clin J Oncol Nurs; 2018 Apr; 22(2):E52-E63. PubMed ID: 29547597
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical trials with antiemetic agents in cancer patients receiving chemotherapy.
    Penta JS; Poster DS; Bruno S; Macdonald JS
    J Clin Pharmacol; 1981; 21(S1):11S-22S. PubMed ID: 6271815
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiemetic effect of delta 9-tetrahydrocannabinol in chemotherapy-associated nausea and emesis as compared to placebo and compazine.
    Orr LE; McKernan JF
    J Clin Pharmacol; 1981; 21(S1):76S-80S. PubMed ID: 6271846
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A controlled double-blind study of trimethobenzamide, prochlorperazine, and placebo.
    Bardfeld PA
    JAMA; 1966 May; 196(9):796-8. PubMed ID: 5326281
    [No Abstract]   [Full Text] [Related]  

  • 37. A randomized, placebo-controlled pilot trial of aprepitant combined with standard antiemetic therapy for the prevention of chemotherapy-induced nausea and vomiting in patients undergoing cyclophosphamide-based conditioning regimens prior to hematopoietic stem cell transplant (HSCT).
    Bubalo J; Mulverhill K; Meyers G; Hayes-Lattin B; Maziarz R
    Bone Marrow Transplant; 2018 Aug; 53(8):1010-1018. PubMed ID: 29459665
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk-benefit of antiemetics in prevention and treatment of chemotherapy-induced nausea and vomiting.
    Herrstedt J
    Expert Opin Drug Saf; 2004 May; 3(3):231-48. PubMed ID: 15155151
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Steroids as antiemetics.
    Ryan GM
    Cancer Nurs; 1983 Apr; 6(2):147-9. PubMed ID: 6339037
    [No Abstract]   [Full Text] [Related]  

  • 40. Treatment of nausea and vomiting in children with diphenidol.
    Marano MJ
    J Med Soc N J; 1967 Mar; 64(3):110-2. PubMed ID: 5342287
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.